A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma.
Academic Article
Publication Date:
2007
Iris type:
1.1 Articolo in rivista
Keywords:
zoledronic acid; osteonecrosis; multiple myeloma.
List of contributors:
Corso, A; Varettoni, M; Zappasodi, P; Lazzarino, Mario; Mangiacavalli, S; Pica, G; Lazzarino, M.
Published in: